| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | President &CEO
3 companies
Higgins John L serves as a Director at OABI and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 9 buys and 48 sells. Those positions are worth an estimated $33.3M at current prices.
Historically, Higgins John L's trades have earned a middling insider score of 66/100 across 18 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +8.8%.
The biggest single holding is LGND (~$27.7M) as Director. The recent filings there lean toward selling, a net 341,329 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2022 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sell | 5,000 | $89.61 | $448,050.00 | -1.4% | -29.3% | -29.4% | |
| Aug 11, 2022 | TECH Bio-Techne Corp | Director | Sale+OE | 2,504 | $378.80 | $948,516.15 | -31.3% | -16.3% | -9.7% | |
| Jun 8, 2022 | TECH Bio-Techne Corp | Director | Sale+OE | 1,600 | $364.98 | $583,964.00 | -25.8% | -9.6% | -12.8% | |
| Nov 12, 2021 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sell | 3,000 | $160.50 | $481,500.00 | -0.9% | -26.0% | -49.6% | |
| Feb 5, 2021 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 54,666 | $203.40 | $11,119,239.33 | -16.0% | - | - | |
| Jan 27, 2021 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 90,000 | $169.22 | $15,230,000.00 | -27.0% | - | - | |
| Nov 6, 2020 | TECH Bio-Techne Corp | Director | Sale+OE | 5,000 | $300.35 | $1,501,744.14 | -53.1% | - | - | |
| Feb 12, 2020 | TECH Bio-Techne Corp | Director | Sale+OE | 5,000 | $205.23 | $1,026,132.50 | -55.4% | - | - | |
| Jul 31, 2019 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Buy | 1,850 | $95.45 | $176,582.50 | +1.3% | - | - | |
| Jun 4, 2019 | TECH Bio-Techne Corp | Director | Sale+OE | 5,000 | $203.67 | $1,018,345.50 | -58.6% | - | - |